Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
Elly C. Klinkenberg–Knol(University of Amsterdam), A. Walan(Linköping University), David Lloyd(St Joseph's Health Centre), Madeline H. Frame(Clinical Science Institute), P. Snel(Slotervaartziekenhuis), Frits Nelis(Amphia Ziekenhuis), John Dent(Royal Adelaide Hospital), Brent Mitchell(Launceston General Hospital), Jonas Román(Cancer Research And Biostatistics), Peter J Prichard(Epworth Hospital), Niilo Havu(Amphia Ziekenhuis)
Cited by 544
Related Papers
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
|Gastroenterology|1988|786
Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer
|New England Journal of Medicine|1989|382